Guest guest Posted April 5, 2004 Report Share Posted April 5, 2004 Rheumawire Apr 5, 2004 Small bowel intestinal bacterial overgrowth linked to pain levels in fibromyalgia Los Angeles - Lactulose breath tests (LBT) suggest that patients with fibromyalgia (FM) have bacterial overgrowth in the small intestine, and the degree of breath test abnormality correlates with somatic pain levels, Dr Mark Pimentel and colleagues report in the ls of the Rheumatic Diseases[1]. " Our most important findings were that FM patients are more likely than controls or inflammatory bowel syndrome (IBS) patients to have abnormal LBT, that FM patients have higher hydrogen profiles, peak hydrogen, and AUC than subjects with IBS, and that somatic pain levels in FM patients correlate with the hydrogen level, " Pimentel tells rheumawire. " What we hope this means is that the bacterial levels are higher in fibromyalgia which could explain the hyperalgesia, since endotoxin is known to produce hyperalgesia. " The researchers had previously reported an association between IBS and abnormal findings on the LBT [2]. They decided to examine LBT data in fibromyalgia patients because bowel complaints are so common in that disease, affecting up to 81% of FM patients [3]. There appears to be a relationship between hydrogen levels on LBT and degree of bacterial load. The study included 42 subjects with FM,111 with IBS, and 15 normal controls. After an overnight fast, baseline LBTs were performed and subjects drank 10g of lactulose syrup. LBT was then repeated every 15 minutes for 3 hours and all test results were coded, randomized, and interpreted by a blinded reader. The LBT was considered normal if there was no rise in hydrogen or methane concentration before 90 minutes after lactulose ingestion and no rise more of more than 20 ppm during 3 hours of measurement. All 42 of the FM subjects had abnormal LBT, versus 84% of the subjects with IBS (p<0.05) and 20% of normal controls (p<0.0001). Hydrogen production was significantly greater in the FM subjects than in the IBS subjects (p<0.01), and peak hydrogen production was significantly higher in the FM subjects than in the IBS group (p<0.00001). " We were very surprised, " Pimentel says. " We had anticipated that there might be a high prevalence of abnormal breath tests but were fortunate to show the dramatically higher hydrogen production in the FM group. " Forty-one of the 42 FM subjects completed visual analogue scores for pain. In these patients, degree of pain correlated significantly with peak hydrogen level (r-0.42, p<0.01), as did area under the curve and pain score. This suggests that bacterial activity in the small bowel is the reason for the correlation between FM pain and LBT findings. " We have no proof in FM that there is an increased endotoxin level, but this is a possible explanation for the findings, " Pimentel says. The investigators write, " What remains to be determined is the relationship between bacteria in the gut and hyperalgesia. " They note that endotoxin produces global hyperalgesia and that translocation of endotoxin-producing enteric organisms does occur in small intestinal bacteria overgrowth. Such translocation has been linked to hepatic inflammation due in part to a TNF-alpha response to endotoxin. The obvious next question is whether using antibiotics to reduce the small bowel bacterial environment and normalize the LBT might produce an improvement in both FM pain and FM bowel complaints. Such an improvement has already been documented for IBS patients treated with antibiotics [2]. " We would like to conduct a double blind, randomized controlled trial [of antibiotic treatment in FM] with endpoints being bowel symptoms, somatic pain levels, and tender points, " Pimentel says. Janis Sources 1. Pimentel M, Wallace D, Hallegua D et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63:450-452. 2. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind placebo-controlled study. Am J Gastroenterol 2003; 98:412-419. 3. Triadafilopoulos G, Simms RW, Goldenberg DI. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991; 36:59-64. I'll tell you where to go! Mayo Clinic in Rochester http://www.mayoclinic.org/rochester s Hopkins Medicine http://www.hopkinsmedicine.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.